Anson M Lee, MD
Cardiac Surgery · Redwood City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 6 carriers
- Offices
- 4
Offices
4 locations · Dignity Health Medical Foundation · Golden State Providers, A Medical Corporation · Stanford Health Care
Looking this up.
Hospitals listed: Good Samaritan Hospital · Sequoia Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
22 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A136787 · Current
Licensed to practise in California · since 2015 · expires 2027-04-30 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$195,878
Medicare paid this office $195,878 for 144 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 28 | $42,703 | $1,525 |
| Replacement of aortic valve through the skin and femoral artery | 45 | $27,583 | $613 |
| New patient visit (60+ min) | 14 | $2,283 | $163 |
| Harvest of vein using an endoscope | 11 | $144 | $13 |
Procedures Medicare counted
| Coronary artery bypass graft (CABG) | 27 | More than 79% of doctors who do this |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
144 Original Medicare patients in 2024. Average age 76 · Women 32% · Also on Medicaid 17% · Health risk score 1.54. At or below the middle of the specialty; the typical cardiac surgery clinician is at 1.73.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Heart failure 69% · Atrial fibrillation 67% · Coronary heart disease 61% · Diabetes 39% · Stroke 22% · Depression 19% · Cancer 16% · COPD 16% · Dementia 9%.
The office billed $1,660,717, Medicare allowed $246,387 and paid $195,878; for 313 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 144 | 313 | 76 | 1.54 | $1,660,717 | $195,878 |
| 2023 | 149 | 271 | 75 | 1.65 | $1,434,587 | $177,265 |
| 2022 | 136 | 261 | 76 | 1.54 | $1,443,001 | $174,093 |
| 2021 | 161 | 393 | 74 | 1.75 | $1,934,520 | $240,062 |
| 2020 | 156 | 322 | 74 | 2.13 | $1,616,604 | $179,373 |
| 2019 | 167 | 378 | 75 | 1.95 | $2,136,716 | $243,973 |
| 2018 | 202 | 423 | 75 | 2.03 | $2,623,304 | $278,367 |
| 2017 | 237 | 565 | 76 | 2.18 | $2,945,442 | $320,149 |
| 2016 | 194 | 452 | 75 | 2.06 | $2,293,538 | $251,842 |
| 2015 | 49 | 90 | 74 | 1.60 | $630,607 | $74,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 29 | $45,307 | $1,562 |
| Replacement of aortic valve through the skin and femoral artery | 38 | $24,174 | $636 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $12,840 | $1,167 |
| Critical care, first 30-74 minutes | 18 | $9,425 | $192 |
| New patient visit (60+ min) | 20 | $3,280 | $164 |
2022: 4 services
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 18 | $28,136 | $1,563 |
| Replacement of aortic valve through the skin and femoral artery | 41 | $26,619 | $649 |
| Critical care, first 30-74 minutes | 13 | $9,156 | $195 |
| New patient visit (60+ min) | 14 | $2,387 | $171 |
2021: 7 services
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 19 | $30,954 | $1,629 |
| Replacement of aortic valve through the skin and femoral artery | 37 | $24,479 | $662 |
| Replacement of aortic valve on heart-lung machine | 15 | $22,947 | $1,530 |
| Removal of defibrillator electrodes through vein | 14 | $10,794 | $771 |
| Critical care, first 30-74 minutes | 20 | $9,767 | $199 |
| New patient visit (60+ min) | 22 | $3,825 | $174 |
| Removal of defibrillator | 13 | $1,325 | $102 |
2020: 4 services
| Replacement of aortic valve through the skin and femoral artery | 43 | $28,586 | $665 |
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 13 | $21,438 | $1,649 |
| Critical care, first 30-74 minutes | 26 | $13,608 | $203 |
| New patient visit (60+ min) | 26 | $3,934 | $151 |
2019: 8 services
| Replacement of aortic valve through the skin and femoral artery | 50 | $37,108 | $728 |
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 16 | $25,727 | $1,608 |
| Replacement of aortic valve on heart-lung machine | 12 | $18,872 | $1,573 |
| Extensive destruction and reconstruction of right upper heart chamber on heart-lung machine | 12 | $8,990 | $749 |
| New patient visit (60+ min) | 23 | $3,491 | $152 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,090 | $91 |
| Short return visit (20+ min) | 12 | $511 | $39 |
| Harvest of vein using an endoscope | 11 | $153 | $14 |
2018: 8 services
| Replacement of aortic valve through the skin and femoral artery | 61 | $42,830 | $702 |
| Extensive reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 21 | $32,334 | $1,540 |
| Replacement of aortic valve on heart-lung machine | 13 | $18,820 | $1,448 |
| Coronary artery bypass using artery graft, 1 graft | 11 | $12,933 | $1,176 |
| New patient visit (60+ min) | 35 | $5,110 | $146 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,307 | $87 |
| Short return visit (20+ min) | 12 | $495 | $41 |
| Harvest of vein using an endoscope | 13 | $173 | $13 |
2017: 11 services
| Replacement of aortic valve through the skin and femoral artery | 70 | $50,867 | $727 |
| Coronary artery bypass using artery graft, 1 graft | 17 | $21,695 | $1,276 |
| Replacement of aortic valve on heart-lung machine | 13 | $21,414 | $1,647 |
| New patient visit (60+ min) | 71 | $10,457 | $147 |
| Coronary artery bypass using vein or artery graft, 2 grafts | 13 | $4,525 | $348 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,882 | $118 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,525 | $90 |
| Removal of defibrillator | 13 | $1,271 | $98 |
| Short return visit (20+ min) | 15 | $717 | $42 |
| Short return visit | 19 | $454 | $22 |
| Harvest of vein using an endoscope | 19 | $260 | $14 |
2016: 7 services
| Replacement of aortic valve through the skin and femoral artery | 58 | $41,371 | $713 |
| Replacement of aortic valve on heart-lung machine | 12 | $21,465 | $1,789 |
| New patient visit (60+ min) | 43 | $6,229 | $145 |
| New patient visit (45+ min) | 16 | $1,673 | $105 |
| New patient visit (30+ min) | 15 | $1,017 | $68 |
| Short return visit (20+ min) | 11 | $456 | $41 |
| Harvest of vein using an endoscope | 12 | $164 | $14 |
2015: 1 service
| New patient visit (60+ min) | 19 | $2,855 | $150 |
Money from drug and device companies
$948 in 2025
| 2025 | 5 | 11 | None | $948 |
| 2024 | 2 | 3 | None | $373 |
| 2023 | 2 | 8 | None | $10,375 |
| 2022 | 2 | 4 | None | $456 |
| 2021 | 2 | 10 | None | $758 |
| 2020 | 1 | 2 | None | $62 |
| 2019 | 2 | 26 | None | $2,320 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $674 | 6 payments
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $170 | 2 payments
|
| Abbott Laboratories | Ensite Precision | $55 | 1 payment
|
| Davol | Arista | $26 | 1 payment
|
| Boston Scientific | General - Therapies | $23 | 1 payment
|
See all 11 published payments
| Edwards Lifesciences | Meals · 2025-12-11 | None | $151 |
| Boston Scientific | Meals · 2025-07-08 | General - Therapies | $23 |
| Davol | Meals · 2025-07-01 | Arista | $26 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $55 |
| AtriCure | Meals · 2025-05-27 | Epi-Sense Guided Coagulation System With Visitrax | $106 |
| AtriCure | Meals · 2025-05-04 | Atricure Cryoice Cryosphere Cryoablation System | $157 |
| AtriCure | Meals · 2025-04-26 | Synergy Ablation System | $90 |
| AtriCure | Meals · 2025-04-25 | Epi-Sense Guided Coagulation System With Visitrax | $32 |
| AtriCure | Meals · 2025-04-24 | Epi-Sense Guided Coagulation System With Visitrax | $148 |
| AtriCure | Meals · 2025-04-14 | Synergy Ablation System | $142 |
| Edwards Lifesciences | Meals · 2025-02-25 | Sapien 3 Ultra Resilia | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $373
| Atricure | Synergy Ablation System | $228 | 2 payments
|
| Boston Scientific | None | $145 | 1 payment
|
2023: $10,375
| Atricure | Synergy Ablation System | $10,184 | 6 payments
|
| Boston Scientific | None | $192 | 2 payments
|
2022: $456
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $243 | 2 payments
|
| Boston Scientific | General - Therapies | $213 | 2 payments
|
2021: $758
| Atricure | Lariat Suture Delivery Device | $439 | 5 payments
|
| Abbott Laboratories | Amplatzer Vascular Plug and Accs | $319 | 5 payments
|
2020: $62
| Atricure | Atricure Synergy Ablation System | $62 | 2 payments
|
2019: $2,320
| AtriCure | Atricure Synergy Ablation System | $2,241 | 25 payments
|
| Medtronic Vascular | Tyrx | $79 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Allergan, Inc. · A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Evaluate the Efficacy and Safety of Botulinum Toxin A Injections Into the Epicardial Fat Pads of Cardiac Surgery Patients To Prevent Post-Operative Atrial Fibrillation · 2021 | Their institution | $44,886 |
| TRANSMEDICS, INC. · Ocs-Lun-Pas01 · 2023 | Their institution | $42,852 |
| TRANSMEDICS, INC. · Ocs-Lun-Pas01 · 2022 | Their institution | $33,600 |
| Allergan, Inc. · A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Evaluate the Efficacy and Safety of Botulinum Toxin A Injections Into the Epicardial Fat Pads of Cardiac Surgery Patients To Prevent Post-Operative Atrial Fibrillation · 2020 | Their institution | $31,325 |
| ATRICURE, INC. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2023 | Their institution | $24,939 |
| TRANSMEDICS, INC. · Ocs-Heart-Ohp-II · 2025 | Their institution | $24,786 |
| TRANSMEDICS, INC. · Ocs Lung Thoracic Organ Perfusion (Top) Registry · 2025 | Their institution | $23,343 |
| TRANSMEDICS, INC. · Ocs-Lun-012013 · 2021 | Their institution | $20,907 |
| AtriCure, Inc. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2025 | Their institution | $18,731 |
| Medtronic Vascular, Inc. · Terminate Af · 2020 | Their institution | $14,450 |
| TRANSMEDICS, INC. · Lung Top Registry · 2020 | Their institution | $11,648 |
| TRANSMEDICS, INC. · Ocs-Lun-012013 · 2022 | Their institution | $11,392 |
| Medtronic, Inc. · Terminate Af · 2022 | Their institution | $9,300 |
| Medtronic, Inc. · Terminate Af · 2025 | Their institution | $8,650 |
| Medtronic, Inc. · Terminate Af · 2021 | Their institution | $7,860 |
| ABBVIE INC. · Botulinum Toxin Type A (Agn-151607) for the Prevention of Post-Operative Atrial Fibrillation in Patients Undergoing Open-Chest Cardiac Surgery (Nova) · 2022 | Their institution | $6,709 |
| Allergan, Inc. · A Multi-Centered, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study To Evaluate the Efficacy and Safety of Botulinum Toxin A Injections Into the Epicardial Fat Pads of Cardiac Surgery Patients To Prevent Post-Operative Atrial Fibrillation · 2022 | Their institution | $3,920 |
| TRANSMEDICS, INC. · Ocs-Lun-Pas01 · 2021 | Their institution | $3,782 |
| Medtronic, Inc. · Terminate Af · 2023 | Their institution | $3,550 |
| TransMedics, Inc. · Lung Registry · 2019 | This clinician | $2,095 |
| TRANSMEDICS, INC. · Ocs-Lun-Pas01 · 2025 | Their institution | $1,984 |
| ATRICURE, INC. · Atriclip Left Atrial Appendage Exclusion Concomitant To Structural Heart Procedures · 2019 | Their institution | $1,952 |
| TRANSMEDICS, INC. · Expand Lung · 2020 | Their institution | $1,920 |
| ATRICURE, INC. · Hybrid Epicardial and Endocardial Sinus Node Sparing Ablation Therapy for Inappropriate Sinus Tachycardia · 2024 | Their institution | $1,600 |
| TRANSMEDICS, INC. · Ocs-Lun-Pas01 · 2024 | Their institution | $1,600 |
| Medtronic, Inc. · Terminate Af · 2024 | Their institution | $1,600 |
| TransMedics, Inc. · Expand Lung · 2019 | This clinician | $1,164 |
| TransMedics, Inc. · Dcd Heart · 2019 | This clinician | $466 |
| TransMedics, Inc. · Lung Research · 2019 | This clinician | $466 |
| TransMedics, Inc. · Expand Heart · 2019 | This clinician | $466 |
| AtriCure, Inc. · Inappropriate Sinus Tachycardiaregistry · 2025 | Their institution | $460 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1336237247
- Licence
- CA A136787, MO 2007015929California A136787: Current · expires 2027-04-30
- Trained
- Washington University School of Medicine, 2005
- Group
- Dignity Health Medical Foundation · Golden State Providers, A Medical Corporation · Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Thoracic surgery (208G00000X); Surgery (208600000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2006-10-10
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 3640 Nw Samaritan Dr Ste 120, Corvallis, OR, 97330
This office lists an electronic records connection.